Beyond beauty with cellular skincare

The Skincare Market is shifting toward clinically inspired actives with measurable outcomes.

This demand is being reflected in category growth across cosmeceuticals and in the expanding market for peptide actives and peptide manufacturing capacity.

Cosmeutical market size

USD 67.1 Billion

3.9% expected CAGR (2025-2030)

$84.6B by 2032

Cosmeceutical Market (2025 - 2030) \ Grand View Research

From label claims to measurable actives.

Peptide actives are increasingly used in cosmetics, but verification is uncommon once ingredients move through multi-step supply chains and complex formulation matrices.

Without analytical confirmation, brands face performance variability and claims risk.

COSMETIC PEPTIDES

Verified peptides, manufactured for consistency

Immobazyme manufactures cosmetic peptides with a quality-first approach. Our focus is on consistent production, evidence-based release testing, and documentation that helps brands formulate reliable and substantial claims.

VIEW OUR CATELOGUE

Increased Yield

High Bioactivity

High Purity

Animal-origin free

Batch consistency

Key Growth Drivers and Trends

Health & Wellness

60%

of consumers across markets report that healthy aging is a “top” or “very important” priority

Efficacy Efficiency

77%

of beauty users demand proven efficacy from at-home products.

This demonstrates a growth in demand for efficacy and efficiency of at-home treatments.

Source Euromonitor

Medical-grade

45%

Consumers are investing time and money in products that improve their long-term health, not just their immediate appearance

Source Euromonitor International

Of Luxury Beauty Shoppers in 2025 are influenced by medical professionals (up from 40% in 2024).

Highlighting that clinical credibility is shaping high-value, purchase decisions.

Source: McKinsey & Company